What are the common side effects of mivamutide? How to recognize and deal with these side effects?

Mifamurtide (Mifamurtide) is an immunotherapy drug commonly used to treat osteosarcoma, especially in high-risk, relapsed cases. Although it has good efficacy in treating osteosarcoma, some side effects may occur during use. Understanding these common side effects and taking appropriate countermeasures are crucial to ensuring the safety and effectiveness of treatment.

1. Fever and chills: One of the most common side effects of mivamutide is fever and chills, which usually occur within 24 hours after the drug is injected. This is because miavastatin activates the immune system, leading to an increase in the release of cytokines in the body, thereby triggering an inflammatory response. Patients may experience symptoms such as elevated body temperature, chills, and fatigue. In most cases, these symptoms are self-limiting and resolve within a few hours. However, if fever symptoms are severe or prolonged, fever-reducing medications (such as acetaminophen) may be needed to relieve discomfort.

2. Muscle and joint pain: Some patients may experience muscle pain and joint pain when treated with mivamutide. These symptoms usually appear in the early stages of drug treatment. Muscle and joint pain is another manifestation of the immune response activated by mivamutin and is often accompanied by other symptoms such as fever and chills. To cope with these discomforts, patients can relieve pain through rest, hot compresses or nonsteroidal anti-inflammatory drugs (NSAIDs). In some cases, if the pain is severe, your doctor may consider adjusting the medication dose or using other symptomatic treatments.

3. Allergic reactions: Although allergic reactions are rare, some patients may develop allergic symptoms such as rash, difficulty breathing or facial swelling when receiving mivarmutide treatment. If these symptoms occur, patients should stop using the medication immediately and seek medical help. People who experience severe allergic reactions may need to be treated with anti-allergic medications such as antihistamines or steroids. During subsequent treatment, patients may be asked to avoid mivamutide or switch to other treatment options.

4. Liver and kidney dysfunction: Mivamutide may affect the function of liver and kidney , especially during long-term use. Patients need to perform regular Liver and kidney function tests to monitor for abnormal liver function or renal insufficiency. If the test results show abnormal liver and kidney function, the doctor may adjust the dose or even suspend treatment. In addition, patients should avoid concurrent use of other medications that may have adverse effects on liver and kidney function, such as certain antibiotics or antifungals.

In short, although the side effects of mivamutide are common, most of them are temporary and can be alleviated with appropriate treatment. During treatment with mivamutide, patients should maintain close contact with their doctors and promptly report any symptoms of discomfort. By promptly identifying and dealing with side effects, the safety of the treatment process can be ensured and the effectiveness of the treatment can be maximized.

xa0

References: https://pubmed.ncbi.nlm.nih.gov/23997016/